Power Law company profile

Pathos

Biotech & Life Sciences · Chicago, United States · Founded 2022 Unicorn

Reimagining drug discovery and development through the lens of technology, with an AI intelligence platform

Valuation

$1–2.5B

Latest valuation · 2026

Unlock exact value

Headcount

<100

Current team size

Unlock exact value

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026

Investors

4 investors on Pathos's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series B+ 4 investors entered at this stage

NEA

Revolution

Builders VC

Lightbank

Global footprint

Where Pathos has talent and traffic

AI talent share

4.3% of workforce is AI talent
(4 of 94 staff)

Core AI22.13%

Other AI22.13%

Non-AI workforce9095.74%

Workforce by country

1 countries with
team presence

🇺🇸 United States100%

1 country shown

Web traffic by country

16K monthly visits
across markets

🇺🇸 United States83.1%

🇨🇦 Canada7.5%

🇬🇧 United Kingdom5%

🇩🇪 Germany1.3%

🇯🇵 Japan0%

Top 5 markets shown

Market sentiment

What the market is saying about Pathos

An AI-synthesized read of the highest-engagement posts about Pathos on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Pathos on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles